🚀 VC round data is live in beta, check it out!
Baird Medical Investment Valuation Multiples
Discover revenue and EBITDA valuation multiples for Baird Medical Investment and similar public comparables like Creo Medical Group, Klea, Bactiguard, Xtant Medical and more.
Baird Medical Investment Overview
About Baird Medical Investment
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.
Founded
2023
HQ
Employees
143
Website
N/A
Sectors
Financials (FY)
EV
$85M
Baird Medical Investment Financials
Baird Medical Investment reported last fiscal year revenue of $37M and EBITDA of $16M.
In the same fiscal year, Baird Medical Investment generated $33M in gross profit, $16M in EBITDA, and $12M in net income.
Baird Medical Investment P&L
In the most recent fiscal year, Baird Medical Investment reported revenue of $37M and EBITDA of $16M.
Baird Medical Investment expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $37M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $33M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 88% | XXX | XXX | XXX |
| EBITDA | — | XXX | $16M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 44% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 41% | XXX | XXX | XXX |
| Net Profit | — | XXX | $12M | XXX | XXX | XXX |
| Net Margin | — | XXX | 34% | XXX | XXX | XXX |
| Net Debt | — | — | $18M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Baird Medical Investment Stock Performance
Baird Medical Investment has current market cap of $65M, and enterprise value of $85M.
Market Cap Evolution
Baird Medical Investment's stock price is $1.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $85M | $65M | -3.3% | XXX | XXX | XXX | $0.34 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBaird Medical Investment Valuation Multiples
Baird Medical Investment trades at 2.3x EV/Revenue multiple, and 5.3x EV/EBITDA.
Baird Medical Investment Financial Valuation Multiples
As of April 11, 2026, Baird Medical Investment has market cap of $65M and EV of $85M.
Equity research analysts estimate Baird Medical Investment's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Baird Medical Investment has a P/E ratio of 5.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $65M | XXX | $65M | XXX | XXX | XXX |
| EV (current) | $85M | XXX | $85M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 5.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 5.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.6x | XXX | XXX | XXX |
| P/E | — | XXX | 5.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (9.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Baird Medical Investment Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Baird Medical Investment Margins & Growth Rates
Baird Medical Investment's revenue in the last fiscal year grew by 18%.
Baird Medical Investment's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Baird Medical Investment Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 44% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 15% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 16% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 17% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 47% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Baird Medical Investment Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Creo Medical Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Klea | XXX | XXX | XXX | XXX | XXX | XXX |
| Bactiguard | XXX | XXX | XXX | XXX | XXX | XXX |
| Xtant Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| FluoGuide | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Baird Medical Investment M&A Activity
Baird Medical Investment acquired XXX companies to date.
Last acquisition by Baird Medical Investment was on XXXXXXXX, XXXXX. Baird Medical Investment acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Baird Medical Investment
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBaird Medical Investment Investment Activity
Baird Medical Investment invested in XXX companies to date.
Baird Medical Investment made its latest investment on XXXXXXXX, XXXXX. Baird Medical Investment invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Baird Medical Investment
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Baird Medical Investment
| When was Baird Medical Investment founded? | Baird Medical Investment was founded in 2023. |
| Where is Baird Medical Investment headquartered? | Baird Medical Investment is headquartered in China. |
| How many employees does Baird Medical Investment have? | As of today, Baird Medical Investment has over 143 employees. |
| Who is the CEO of Baird Medical Investment? | Baird Medical Investment's CEO is Haimei Wu. |
| Is Baird Medical Investment publicly listed? | Yes, Baird Medical Investment is a public company listed on Nasdaq. |
| What is the stock symbol of Baird Medical Investment? | Baird Medical Investment trades under BDMD ticker. |
| When did Baird Medical Investment go public? | Baird Medical Investment went public in 2024. |
| Who are competitors of Baird Medical Investment? | Baird Medical Investment main competitors are Creo Medical Group, Klea, Bactiguard, Xtant Medical. |
| What is the current market cap of Baird Medical Investment? | Baird Medical Investment's current market cap is $65M. |
| What is the current revenue of Baird Medical Investment? | Baird Medical Investment's last fiscal year revenue is $37M. |
| What is the current EV/Revenue multiple of Baird Medical Investment? | Current revenue multiple of Baird Medical Investment is 2.3x. |
| Is Baird Medical Investment profitable? | No, Baird Medical Investment is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.